A review of 65 years of human adenovirus seroprevalence
Franck J. D. Mennechet(Centre National de la Recherche Scientifique), Océane Paris(Centre National de la Recherche Scientifique), Aline Raissa Ouoba(Centre National de la Recherche Scientifique), Sofia Salazar Arenas(Centre National de la Recherche Scientifique), Sodiomon B. Sirima(Centre National de Recherche et de Formation sur le Paludisme), Guy R. Takoudjou Dzomo(University of N'Djamena), Amidou Diarra(Centre National de Recherche et de Formation sur le Paludisme), Isidore T Traore(Centre Muraz), Dramane Kania(Centre Muraz), Karsten Eichholz(Centre National de la Recherche Scientifique), Eric A. Weaver(University of Nebraska–Lincoln), Édouard Tuaillon(Inserm), Eric J. Kremer(Centre National de la Recherche Scientifique)
Cited by 181Open Access
Abstract
: Vaccination is among the most efficient tools to prevent infectious disease. HAdV-based vaccines have undeniable potential, but optimization is needed and antivector immunity remains a challenge if the same vectors are to be administrated to different populations. Here, we identify gaps in our knowledge and the need for updated worldwide epidemiological data.
Related Papers
No related papers found
Powered by citation graph analysis